Bookmark and Share

 

LITIGATION

» Access to Courts and Court Remedies

» Campaign Finance and Election Laws

» Constitutional Rights and Requirements

» Health, Safety, and Environment

» Open Government and Open Courts

» Representing Consumers

» Workers' Rights


Currently Featured Topics

Government Transparency
Consumer Justice
First Amendment
Health, Safety and the Environment

SUPREME COURT
ASSISTANCE PROJECT

Read about our work helping lawyers
with cases in the Supreme Court.

 


Public Citizen | America's Other Drug Problem - rxfacts index

America's Other Drug Problem:
A Briefing Book on the Rx Drug Debate 

*Updated April 2003

* Note:
You will need Adobe Acrobat Reader to open and read these documents. If you do not have Acrobat Reader, you can access this free software by clicking on the graphic. You will only have to complete this process once.
Get Acrobat Reader 


America's Other Drug Problem: A Briefing Book on the Rx Drug Debate is a comprehensive resource guide about the prescription drug issues that are at the center of the legislative debates in Congress and state capitals around the country. 

It includes information on the following topics:

  • The extent and type of prescription drug coverage held by Americans;
  • Facts about the overall increased spending on drugs and rising drug prices, including international price comparisons;
  • The extent of advertising and marketing of prescription drugs, with a special focus on direct-to-consumer advertising;
  • Drug company profits, including a historical analysis and cross-industry comparisons;
  • The cost of researching and developing new drugs, including a critique of industry claims and the therapeutic importance of new drugs;
  • Taxpayer subsidies for the drug industry, including cross-industry comparisons;
  • Patent protections for new drugs and patent extension tricks for older drugs that are used to delay generic competition; and
  • Campaign contributions and lobbying spending by the drug industry.


To view the resource guide, please click here.

 

Copyright © 2010 Public Citizen. All rights reserved. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation.  Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.